Gα12 Protein

Gα12 Protein

Introduction

Gα12 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@hubbard2000]
<table> [@riobo2006]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.2em;">Gα12 Protein</th></tr> [@fraser2008]
<tr><td><strong>Protein Name</strong></td><td>Guanine Nucleotide-Binding Protein Subunit Alpha-12</td></tr> [@zhang2021]
<tr><td><strong>Gene</strong></td><td>[GNA12 Gene](/proteins/gna12-protein)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9UBF6](https://www.uniprot.org/uniprot/Q9UBF6)</td></tr>
<tr><td><strong>PDB ID(s)</strong></td><td>1ZCA, 2R3R</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>44.0 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Plasma membrane, Cytoskeleton</td></tr>
<tr><td><strong>Protein Family</strong></td><td>G12 family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Autism spectrum disorder, Cancer metastasis, Hypertension</td></tr>
</table>
</div>

Overview

Gα12 Protein

Introduction

Gα12 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@hubbard2000]
<table> [@riobo2006]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.2em;">Gα12 Protein</th></tr> [@fraser2008]
<tr><td><strong>Protein Name</strong></td><td>Guanine Nucleotide-Binding Protein Subunit Alpha-12</td></tr> [@zhang2021]
<tr><td><strong>Gene</strong></td><td>[GNA12 Gene](/proteins/gna12-protein)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9UBF6](https://www.uniprot.org/uniprot/Q9UBF6)</td></tr>
<tr><td><strong>PDB ID(s)</strong></td><td>1ZCA, 2R3R</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>44.0 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Plasma membrane, Cytoskeleton</td></tr>
<tr><td><strong>Protein Family</strong></td><td>G12 family</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Autism spectrum disorder, Cancer metastasis, Hypertension</td></tr>
</table>
</div>

Overview

The Gα12 protein (Guanine Nucleotide-Binding Protein Subunit Alpha-12) is a member of the G12 family of heterotrimeric G protein alpha subunits. These proteins function as molecular switches that transmit signals from G protein-coupled receptors (GPCRs) to downstream effector proteins, regulating various cellular processes including calcium signaling, phosphoinositide metabolism, and cytoskeletal dynamics.

Structure

The Gα12 protein consists of:

• GTP-binding domain: Binds GTP/GDP and undergoes conformational changes
• Switch regions (I, II, III): Undergo structural changes during GTP hydrolysis
• Helical domain: Covers the nucleotide-binding pocket
• Effector-binding interface: Interacts with downstream target proteins

Normal Function

As a G protein alpha subunit, Gα12 cycles between active (GTP-bound) and inactive (GDP-bound) states:

The G12 family proteins activate distinct downstream effectors:

• Gq/11: Activate phospholipase C-beta (PLCβ), leading to IP3/DAG production and calcium release
• G12/13: Activate RhoGEFs, regulating cytoskeletal remodeling and cell migration
• Gi/o: Inhibit adenylate cyclase and activate GIRK channels

Role in Disease

[Autism Spectrum Disorder](/diseases/autism-spectrum-disorder), [Hypertension](/diseases/hypertension)

Dysregulation of Gα12 signaling contributes to various diseases through:

• Altered neuronal excitability and synaptic transmission
• Dysregulated calcium homeostasis
• Abnormal cell proliferation and migration
• Impaired synaptic plasticity

Therapeutic Targeting

While Gα12 itself has been challenging to target directly, several strategies are being explored:

| Approach | Status | Description |
|----------|--------|-------------|
| GPCR modulators | Approved | Drugs targeting upstream GPCRs that activate G12 family proteins |
| PLCβ inhibitors | Research | Downstream effectors of Gq signaling |
| Rho pathway inhibitors | Research | For G12/13-mediated cytoskeletal effects |

Background

The study of Gα12 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Ron D, et al (1998). G12/13 signaling pathways. Oncogene. 17(17):2273-2278. PMID: 9816982(https://pubmed.ncbi.nlm.nih.gov/9816982/).

Kelly P, et al (2008). G12 family in cell growth and differentiation. Cell Signal. 20(12):2126-2133. PMID: 18634871(https://pubmed.ncbi.nlm.nih.gov/18634871/).

Mooberry SE, et al (2017). G12/13 in cancer metastasis. Small GTPases. 8(2):90-97. PMID: 27124610(https://pubmed.ncbi.nlm.nih.gov/27124610/).

Fukuhara S, et al (2001). G12/13 and Rho activation. J Biol Chem. 276(50):46225-46235. PMID: 11568177(https://pubmed.ncbi.nlm.nih.gov/11568177/).

Guenther EE, et al (2020). G12 proteins in development. Dev Biol. 460(2):163-173. PMID: 32142706(https://pubmed.ncbi.nlm.nih.gov/32142706/).

See Also

• [G Proteins](/entities/g-proteins) [GPCR Signaling](/mechanisms/gpcr-signaling)
• [Calcium Signaling](/mechanisms/calcium-signaling)
• [Phospholipase C Pathway](/mechanisms/phospholipase-c-signaling)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Epilepsy](/diseases/epilepsy)
• [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder)